Results 231 to 240 of about 141,219 (262)

[Amyloid light-chain (AL) amyloidosis and follicular lymphoma: a case report]. [PDF]

Pan Afr Med J
Benmoussa A, Maatoui-Belabbes H, Allali R, Regragui M, Qachouh M, Cherkaoui S, Lamchahab M, Rachid M, Madani A, Khoubila N.   +9 more
europepmc   +1 more source

Gastroduodenal Involvement in AL Amyloidosis: Case Report and Literature Review. [PDF]

J Investig Med High Impact Case Rep
Ramachandran R, Grantham T, Isaac-Coss G, Etienne D, Reddy M.   +4 more
europepmc   +1 more source

Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design. [PDF]

Leukemia
Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Kourelis T, Warsame R, Muchtar E, Leung N, Kapoor P, Grogan M, Go R, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Gertz MA, Dispenzieri A.   +22 more
europepmc   +1 more source

Changes in the clinical features, treatments, and outcomes of patients with systemic light chain (AL) amyloidosis in Western China, 2010-2022: A multicenter, retrospective, real-world study. [PDF]

Chin Med J (Engl)
Yu H, Zhao L, Li J, Zhang C, Liu Q, Zhou J, Xu F, Xiao J, Yuan Y, Yan S, Chen Y, Zhang Q, Shang H, Hu Z, Wu Y.   +14 more
europepmc   +1 more source

Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures. [PDF]

Leukemia
Zanwar S, Gertz MA, Muchtar E, Buadi FK, Kourelis T, Gonsalves W, Go RS, Hayman S, Kapoor P, Binder M, Cook J, Dingli D, Leung N, Lin Y, Warsame R, Fonder A, Hobbs M, Hwa YL, Kyle RA, Rajkumar SV, Kumar S, Dispenzieri A.   +21 more
europepmc   +1 more source

Amyloid Light-Chain (AL) Amyloidosis of the Trachea Associated With an Indolent B-cell Neoplasm. [PDF]

Cureus
Trikannad AK, Shrestha A, Vellanki S, Cheema HI, Patel TH, Bachu R, Sharma S, Jeffus SK, Thanendrarajan S.   +8 more
europepmc   +1 more source

Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expression. [PDF]

Ann Hematol
Rieger MJ, Pabst T, Jeker B, Paul P, Bergamini F, Bühler MM, Condoluci A, Flammer AJ, Rossi D, Stussi G, Gerber B, Schwotzer R.   +11 more
europepmc   +1 more source

Correction to "Risk factors for severe infection and mortality in patients with COVID-19 in patients with multiple myeloma and AL amyloidosis". [PDF]

Am J Hematol
europepmc   +1 more source